Radiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas

Acta Oncologica

Volumn 38, Issue 8, 1999, Pages 1031-1035

  Serin, Meltem ^a   Erkal, Haldun Ş ^a,b   Çakmak, Ahmet ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE; STATISTICAL ANALYSIS; SURVIVAL RATE;

EID: 0033427216     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699432310     Document Type: Article

References (29)

1. Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5 037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992; 23: 261-70.
2. Perez CA, Devineni VR, Marcial-Vega V, Marks JE, Simpson JR, Kucik N. Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992; 23: 271-80.
3. Sanguineti G, Geara FB, Garden AS, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys 1997; 37: 985-96.
4. Sham JST, Choy D. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br J Radiol 1990; 63: 51-8.
5. Al-Kourainy K, Crissman J, Ensley J, Kish J, Kelly J, Al-Sarraf M. Excellent response to cis-platinum-based chemotherapy in patients with recurrent or previously untreated advanced nasopharyngeal carcinoma. Am J Clin Oncol 1988; 11: 427-30.
6. Al-Sarraf M, Pajak TF, Cooper JS, Mohiuddin M, Hersekovic A, Ager PJ. Ager PJ. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a Radiation Therapy Oncology Group study. J Clin Oncol 1990; 8: 1342-51.
7. Atichartakarn V, Kraiphibul P, Clongsusuek P, Pochanugool L. Kulapaditharom B, Ratanatharathorn V. Nasopharyngeal carcinoma: result of treatment with cis-diamminedichloroplatinum II, 5-fluorouracil and radiation therapy. Int J Radiat Oncol Biol Phys 1988; 14: 461-9.
8. Clark JR, Norris CM, Dreyfuss AI, et al. Nasopharyngeal carcinoma: the Dana-Farber Cancer Institute experience with 24 patients treated with induction chemotherapy and radiotherapy. Ann Otol Rhinol Laryngol 1987; 96: 608-13.
9. Tannock I, Payne D, Cummings B, Hewitt K, Panzarella T. Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long-term benefit despite a high rate of tumor response to chemotherapy. J Clin Oncol 1987; 5: 629-34.
10. Lee AW, Chan DK, Fowler JF, et al. Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma. Radiother Oncol 1995; 36: 24-31.
11. Leibel SA, Kutcher GJ, Harrison LB, et al. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 1991; 20: 823-33.
12. Wang CC. Radiation therapy for head and neck neoplasms. 3rd ed., New York: Wiley-Liss, Inc., 1997.
13. Rossi A, Molinari R, Boracchi P, Vecchio MD, Marubini E, Nava M. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol 1988; 6: 1401-10.
14. Bachouchi M, Cvitkovic E, Azli N, et al. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin and cisplatin before radiotherapy. J Natl Cancer Inst 1990; 82: 616-20.
15. Dimery IW, Peters LJ, Goepfert H, et al. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol 1993; 11: 1919-28.
16. Chan AT, Teo PM, Leung TW, et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1995; 33: 569-77.
17. Chua DT, Sham JS, Choy D, et al. Preliminary report of the Asian Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer 1998; 83: 2270-83.
18. International Nasopharynx Cancer Study Group. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV ( ≥ N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Radiat Oncol Biol Phys 1996; 35: 463-9.
19. Souhami L, Rabinowits M. Combined treatment in carcinoma of the nasopharynx. Laryngoscope 1988; 98: 881-3.
20. Turner SL, Tiver KW. Synchronous radiotherapy and chemotherapy in the treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1993; 27: 371-7.
21. Dewit L. Combined treatment of radiation and cis-diamminedichloroplatinum (II): a review of experimental and clinical data. Int J Radiat Oncol Biol Phys 1987; 13: 403-26.
22. Forastiere AA. Cisplatin and radiotherapy in the management of locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1993; 27: 465-70.
23. Forastiere AA. Concurrent cisplatinum and radiation for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1995; 31: 679-80.
24. Fu KK, Phillips TL. Biological rationale of combined radiotherapy and chemotherapy. Hematol Oncol Clin North Am 1991; 5: 725-36.
25. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 1998; 16: 1310-7.
26. Chan AT, Teo PM, Leung TW, Johnson PJ. The role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer 1998; 82: 1003-12.
27. Choi KN, Rotman M, Aziz H, et al. Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors. Int J Radiat Oncol Biol Phys 1997; 39: 823-9.
28. Lin JC, Chen KY, Jan JS, Hsu CY. Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1996; 36: 1127-36.
29. Cheng SH, Jian JJ, Tsai SY, et al. Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 1998; 41: 755-62.